EVARF vs ABT: Which Stock is Better?
Side-by-side comparison of Lombard Medical Inc and Abbott Laboratories in 2026
EVARF
Lombard Medical Inc
$0.00
ABT
Abbott Laboratories
$121.14
Key Metrics Comparison
| Metric | EVARF | ABT | Winner |
|---|---|---|---|
| Market Cap | $0.00M | $211.92B | ABT |
| P/E Ratio | N/A | 15.30 | ABT |
| EPS (TTM) | $N/A | $7.96 | ABT |
| Revenue Growth | -0.2% | 0.1% | ABT |
| Gross Margin | 9.4% | 56.3% | ABT |
Analyze EVARF
Full quant analysis
Analyze ABT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is EVARF or ABT a better investment?
Comparing EVARF and ABT: Lombard Medical Inc has a market cap of $0.00M while Abbott Laboratories has $211.92B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between EVARF and ABT?
EVARF (Lombard Medical Inc) and ABT (Abbott Laboratories) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: EVARF or ABT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: EVARF or ABT?
ABT has higher revenue growth at 0.1% vs -0.2% for EVARF.
Which company is more profitable: EVARF or ABT?
Abbott Laboratories (ABT) has higher gross margins at 56.3% compared to 9.4% for EVARF.
Which is the larger company: EVARF or ABT?
Abbott Laboratories (ABT) is larger with a market cap of $211.92B compared to $0.00M for EVARF.
Should I buy EVARF or ABT in 2026?
Both EVARF and ABT have investment merit. EVARF trades at $0.00 while ABT trades at $121.14. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between EVARF and ABT stock?
Key differences: Market Cap ($0.00M vs $211.92B), P/E Ratio (N/A vs 15.3x), Revenue Growth (-0.2% vs 0.1%), Gross Margin (9.4% vs 56.3%).